AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 119 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $27,050,000 | +14.6% | 2,877,512 | -6.7% | 0.00% | 0.0% |
| Q2 2020 | $23,596,000 | +22.1% | 3,084,439 | -1.4% | 0.00% | 0.0% |
| Q1 2020 | $19,333,000 | -43.8% | 3,128,350 | +10.7% | 0.00% | 0.0% |
| Q4 2019 | $34,407,000 | -4.3% | 2,827,229 | -9.1% | 0.00% | 0.0% |
| Q3 2019 | $35,937,000 | +30.0% | 3,111,319 | +12.5% | 0.00% | 0.0% |
| Q2 2019 | $27,634,000 | -42.9% | 2,766,237 | -26.4% | 0.00% | -50.0% |
| Q1 2019 | $48,386,000 | -5.2% | 3,756,733 | +11.9% | 0.00% | 0.0% |
| Q4 2018 | $51,015,000 | -22.3% | 3,358,459 | +2.3% | 0.00% | -33.3% |
| Q3 2018 | $65,638,000 | +4.8% | 3,281,854 | +2.2% | 0.00% | 0.0% |
| Q2 2018 | $62,640,000 | -5.5% | 3,212,304 | -2.3% | 0.00% | 0.0% |
| Q1 2018 | $66,276,000 | +49.1% | 3,289,115 | -1.9% | 0.00% | +50.0% |
| Q4 2017 | $44,448,000 | -25.2% | 3,354,520 | +4.1% | 0.00% | -33.3% |
| Q3 2017 | $59,440,000 | +7.4% | 3,221,655 | +7.1% | 0.00% | 0.0% |
| Q2 2017 | $55,336,000 | -20.5% | 3,007,424 | -2.5% | 0.00% | -25.0% |
| Q1 2017 | $69,576,000 | -31.3% | 3,085,348 | +6.1% | 0.00% | -33.3% |
| Q4 2016 | $101,216,000 | +45.2% | 2,908,516 | +2.3% | 0.01% | +50.0% |
| Q3 2016 | $69,704,000 | +4.2% | 2,843,905 | +1.7% | 0.00% | 0.0% |
| Q2 2016 | $66,897,000 | +4.5% | 2,796,692 | +2.3% | 0.00% | 0.0% |
| Q1 2016 | $63,987,000 | -11.7% | 2,734,502 | +13.9% | 0.00% | -20.0% |
| Q4 2015 | $72,451,000 | -86.8% | 2,399,846 | -82.7% | 0.01% | -76.2% |
| Q3 2015 | $550,744,000 | +425.5% | 13,894,422 | +815.6% | 0.02% | +200.0% |
| Q2 2015 | $104,801,000 | +96.2% | 1,517,530 | +55.3% | 0.01% | +75.0% |
| Q1 2015 | $53,414,000 | +72.5% | 977,223 | +34.5% | 0.00% | +100.0% |
| Q4 2014 | $30,961,000 | +31.2% | 726,465 | -1.8% | 0.00% | 0.0% |
| Q3 2014 | $23,595,000 | +56.6% | 739,411 | +1.7% | 0.00% | +100.0% |
| Q2 2014 | $15,067,000 | +8.4% | 727,158 | +1.3% | 0.00% | 0.0% |
| Q1 2014 | $13,895,000 | -17.7% | 718,083 | +3.2% | 0.00% | 0.0% |
| Q4 2013 | $16,893,000 | +21.1% | 696,047 | +7.2% | 0.00% | 0.0% |
| Q3 2013 | $13,945,000 | +1.1% | 649,221 | +4.7% | 0.00% | 0.0% |
| Q2 2013 | $13,798,000 | – | 620,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
| Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
| Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
| Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
| Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
| AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
| ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
| ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |